Sponsored Videos

Real-World Evidence: Real World Uses and the Regulatory Vision Forward

December 1st 2020

Sponsored Video

Using Digital Innovation to Transform Clinical Development

ByClarivate Analytics

October 27th 2020

Expedited Programs for Drug Approvals

August 7th 2020

Modernizing Drug Development in the Face of the COVID-19 Pandemic

April 16th 2020

Real-World Data: Exploring Possibilities and Overcoming Obstacles

July 17th 2019

Executive Search Tips

July 15th 2019

Increasing Transparency & Building Trust

June 5th 2019

Oracle Clinical Data Management

July 25th 2018

Trending on PharmExec

Pharmaceutical Executive Daily: Foghorn Therapeutics & Eli Lilly Discontinue Development of FHD-909

Roundup: Novartis & Abogen Enter Licensing and Option Agreement, AstraZeneca and Daiichi Sankyo Enter Clinical Collaboration with Summit Therapeutics

New U.S. Guidance Lays Out Exemptions for 100% Tariffs: Report

Foghorn Therapeutics & Eli Lilly Halt Fhd-909 Development Following Phase I Data

FDA Approves Expanded Indication for Camzyos for Symptomatic Obstructive Hypertrophic Cardiomyopathy